SAVA Q2 2018 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1,463

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.36

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$699,000

Balance Sheet

Total Assets

$10M

Total Liabilities

$1M

Stockholders' Equity

$9M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,463	-$3,063	+52.2%
Operating Income	-$2M	-$4M	+40.9%
Net Income	-$2M	-$4M	+41.1%